Press release
Spanish pharmaceutical company Zendal and IAVI partner to advance the tuberculosis vaccine candidate MTBVAC into efficacy trials
Spanish pharmaceutical company Zendal and IAVI partner to advance the tuberculosis…
MTBVAC, a live TB vaccine poised to initiate efficacy trials 100 years after BCG Vaccine
MTBVAC, a live TB vaccine poised to initiate efficacy trials 100 years after BCG Vaccine…
The Minister of Health Carolina Darias visits the facilities of the Zendal Group
The Minister of Health Carolina Darias visits the facilities of the Zendal Groupvacuna…
Zendal is committed to the creation of a biotechnological pole Galicia-North of Portugal
Zendal is committed to the creation of a biotechnological pole Galicia-North of Portugal…
A USC SARS-COV-2 vaccine project and animal paratuberculosis mycobacteria research, winners of the II International Zendal Awards
A USC SARS-COV-2 vaccine project and animal paratuberculosis mycobacteria research,…
Biofabri of Zendal Group has been selected by the CEPI as a strategic facility to increase the manufacturing capacity of Covid-19 vaccines at an international scale
Biofabri of Zendal Group has been selected by the CEPI as a strategic facility to…
Zendal Research Awards 2020 announced. In this edition the award money is increased
Zendal Research Awards 2020 announced. In this edition the award money is increased…
Zendal Groups biopharmaceutical facilities received today a visit by the Science and Innovation Minister, Pedro Duque
Zendal Groups biopharmaceutical facilities received today a visit by the Science and…
CZ VACCINES closed 2019 financial year with a 4,3% increase in annual turnover, compared to 2018.
CZ VACCINES closed 2019 financial year with a 4,3% increase in annual turnover, compared…
Zendal rewards the GENVIP research group and pays homage to the scientist María Vallet in the first edition of its awards
Zendal rewards the GENVIP research group and pays homage to the scientist María Vallet in…
